![Othmar Zenker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Othmar Zenker worked as the Global Head-Immunology at CSL Behring GmbH from 2000 to 2012.
He also worked as the Chief Medical Officer at InflaRx NV.
Dr. Zenker received a doctorate degree from the University of Kiel in 1990.
Eerdere bekende functies van Othmar Zenker
| Bedrijven | Functie | Einde |
|---|---|---|
CSL Behring GmbH
 CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Corporate Officer/Principal | 01-01-2012 |
| INFLARX N.V. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Othmar Zenker
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
17
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Kiel
 University of Kiel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring GmbH
CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Health Technology |
InflaRx NV
 InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Kies MarketScreener 
